Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000479643 | SCV000570256 | likely pathogenic | not provided | 2016-05-05 | criteria provided, single submitter | clinical testing | The Y35X variant in the DLD gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The Y35X variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The Y35X variant is a strong candidate for a pathogenic variant; however, the possibility it may be a rare benign variant cannot be excluded. |
Revvity Omics, |
RCV000984255 | SCV003828929 | likely pathogenic | Pyruvate dehydrogenase E3 deficiency | 2022-12-16 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000984255 | SCV004193974 | likely pathogenic | Pyruvate dehydrogenase E3 deficiency | 2023-03-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000984255 | SCV004530507 | pathogenic | Pyruvate dehydrogenase E3 deficiency | 2024-01-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr35*) in the DLD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DLD are known to be pathogenic (PMID: 8968745, 9934985). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with dihydrolipoamide dehydrogenase deficiency (PMID: 8968745). ClinVar contains an entry for this variant (Variation ID: 421142). For these reasons, this variant has been classified as Pathogenic. |
Counsyl | RCV000984255 | SCV001132379 | likely pathogenic | Pyruvate dehydrogenase E3 deficiency | 2014-07-28 | no assertion criteria provided | clinical testing |